Paschka P - Articles from Medline

Last articles by author Paschka P

27 articles found

Journal of clinical oncology : official journal of the American Society of Clinical Oncology
19/06/2008
Patients With Acute Myeloid Leukemia and RAS Mutations Benefit Most From Postremission High-Dose Cytarabine: A Cancer and Leukemia Group B Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
19/06/2008
Wilms Tumor 1 Gene Mutations Independently Predict Poor Outcome in Adults With Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study.
The New England journal of medicine
10/05/2008
MicroRNA expression in cytogenetically normal acute myeloid leukemia.
Blood
02/07/2008
High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B (CALGB) study.
Haematologica
02/04/2008
Dynamics of BCR-ABL mutated clones prior to hematologic or cytogenetic resistance to imatinib.
Blood
28/03/2008
FLT3 D835/I836 mutations are associated with poor disease-free survival and a distinct gene-expression signature among younger adults with de novo cytogenetically normal acute myeloid leukemia lacking FLT3 internal tandem duplications.
Haematologica
21/09/2007
An international study to standardize the detection and quantitation of BCR-ABL transcripts from stabilized peripheral blood preparations by quantitative RT-PCR.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
14/09/2007
High expression levels of the ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B Study.
The Journal of pharmacology and experimental therapeutics
31/07/2007
Targeting AML1/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cells.
Blood
14/09/2007
Long-term disease-free survivors with cytogenetically normal acute myeloid leukemia and MLL partial tandem duplication: a Cancer and Leukemia Group B study.

National Library of Medicine

Create email alert

Send to a friend

Doctors UK Consultants UK

Articles from other specialties:

Paediatrics, Intensive Care, Rheumatology, Neurology, Neurosurgery, Allergy, Psychiatry, Nuclear Medicine, Endocrinology, Gastroenterology, Thoracic Surgery, Otorhinolaryngology, Gynaecology - Obstetrics